Literature DB >> 32148447

Effectiveness of Bidirectional Glenn Shunt Placement for Palliation in Complex Congenitally Corrected Transposed Great Arteries.

Kai Ma, Lei Qi, Zhongdong Hua, Keming Yang, Hao Zhang, Shoujun Li, Sen Zhang, Fengpu He, Guanxi Wang.   

Abstract

Surgery for complex congenitally corrected transposed great arteries is one of the greatest challenges in cardiovascular surgery. We report our experience with bidirectional Glenn shunt placement as a palliative procedure for complex congenitally corrected transposition. We retrospectively identified 50 consecutive patients who had been diagnosed with congenitally corrected transposition accompanied by left ventricular outflow tract obstruction and ventricular septal defect and who had then undergone palliative bidirectional Glenn shunt placement at our institution from January 2005 through December 2014. Patients were divided into 3 groups according to subsequent surgeries: Fontan completion (total cavopulmonary connection, 13 patients) (group 1), anatomic repair (hemi-Mustard and Rastelli procedures without Glenn takedown, 11 patients) (group 2), and prolonged palliation (no further surgery, 26 patients) (group 3). After shunt placement, no patient died or had ventricular dysfunction. Overall, mean oxygen saturation increased significantly from 79.5% ± 13.5% preoperatively to 94.1% ± 7.3% (P <0.001). The median time from shunt placement to Fontan completion and anatomic repair, respectively, was 2.1 years (range, 1.6-5.2 yr) and 1.1 years (range, 0.6-2.4 yr). Only 2 late deaths occurred, both in group 1. In group 3, time from shunt placement to latest follow-up was 4.5 years (range, 2.3-8 yr). At latest follow-up, mean oxygen saturation was 91.6% ± 10.3%, and no patients had impaired ventricular function. Bidirectional Glenn shunt placement as an optional palliative procedure for complex congenitally corrected transposition has favorable outcomes. Later, patients can feasibly be treated by Fontan completion or anatomic repair. Use of a bidirectional Glenn shunt for open-ended palliation is also acceptable.
© 2020 by the Texas Heart® Institute, Houston.

Entities:  

Keywords:  Abnormalities, multiple/surgery; Fontan procedure/adverse effects; arteriovenous shunt, surgical/methods; cardiac surgical procedures/methods; disease-free survival; reoperation; retrospective studies; transposition of great vessels/complications/physiopathology/surgery; treatment outcome; ventricular function

Mesh:

Year:  2020        PMID: 32148447      PMCID: PMC7046347          DOI: 10.14503/THIJ-17-6555

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  28 in total

1.  Mid-term results of bidirectional cavopulmonary anastomosis and hemi-Mustard procedure in anatomical correction of congenitally corrected transposition of the great arteries.

Authors:  Vladimir Sojak; Irene Kuipers; Dave Koolbergen; Marry Rijlaarsdam; Jaroslav Hruda; Nico Blom; Mark Hazekamp
Journal:  Eur J Cardiothorac Surg       Date:  2012-03-07       Impact factor: 4.191

2.  Midterm results after restoration of the morphologically left ventricle to the systemic circulation in patients with congenitally corrected transposition of the great arteries.

Authors:  Stephen M Langley; David S Winlaw; Oliver Stumper; Rami Dhillon; Joseph V De Giovanni; John G Wright; Paul Miller; Babulal Sethia; David J Barron; William J Brawn
Journal:  J Thorac Cardiovasc Surg       Date:  2003-06       Impact factor: 5.209

3.  Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists.

Authors:  Rebecca T Hahn; Theodore Abraham; Mark S Adams; Charles J Bruce; Kathryn E Glas; Roberto M Lang; Scott T Reeves; Jack S Shanewise; Samuel C Siu; William Stewart; Michael H Picard
Journal:  J Am Soc Echocardiogr       Date:  2013-09       Impact factor: 5.251

Review 4.  Root translocation in congenitally corrected transposition of the great arteries with ventricular septal defect and pulmonary stenosis, and other lesions.

Authors:  Jose Pedro Da Silva; Luciana Fonseca Da Silva; Jose Francisco Baumgratz; Rodrigo Moreira Castro; Rodrigo Freire Bezerra; Jose Cicero Guilhen
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2015

5.  Outcome after surgical repair/palliation of congenitally corrected transposition of the great arteries.

Authors:  J Hörer; C Schreiber; S Krane; Z Prodan; J Cleuziou; M Vogt; K Holper; R Lange
Journal:  Thorac Cardiovasc Surg       Date:  2008-09-22       Impact factor: 1.827

Review 6.  Atrioventricular valve repair in patients with single-ventricle physiology: mechanisms, techniques of repair, and clinical outcomes.

Authors:  Osami Honjo; Luc Mertens; Glen S Van Arsdell
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2011

7.  Long-term results of the lateral tunnel Fontan operation.

Authors:  C Stamm; I Friehs; J E Mayer; D Zurakowski; J K Triedman; A M Moran; E P Walsh; J E Lock; R A Jonas
Journal:  J Thorac Cardiovasc Surg       Date:  2001-01       Impact factor: 5.209

8.  Trends in Fontan surgery and risk factors for early adverse outcomes after Fontan surgery: the Australia and New Zealand Fontan Registry experience.

Authors:  Ajay J Iyengar; David S Winlaw; John C Galati; David S Celermajer; Gavin R Wheaton; Thomas L Gentles; Leeanne E Grigg; Robert G Weintraub; Andrew Bullock; Robert N Justo; Yves d'Udekem
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-23       Impact factor: 5.209

9.  Results of Fontan operation in patients with congenitally corrected transposition of great arteries†.

Authors:  Sachin Talwar; Ashwani Bansal; Shiv Kumar Choudhary; Shyam Sunder Kothari; Rajnish Juneja; Anita Saxena; Balram Airan
Journal:  Interact Cardiovasc Thorac Surg       Date:  2015-11-20

10.  Combined arterial switch and Senning operation for congenitally corrected transposition of the great arteries: patient selection and intermediate results.

Authors:  Eric J Devaney; John R Charpie; Richard G Ohye; Edward L Bove
Journal:  J Thorac Cardiovasc Surg       Date:  2003-03       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.